- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Celldex Therapeutics (CLDX)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 36.04 mm | 36.04 mm | 36.04 mm | 36.04 mm | 36.04 mm | 36.04 mm |
| Cash burn (monthly) | (no burn) | 30.17 k | 24.54 mm | 21.35 mm | 16.21 mm | 14.96 mm |
| Cash used (since last report) | n/a | 129.87 k | 105.65 mm | 91.93 mm | 69.78 mm | 64.39 mm |
| Cash remaining | n/a | 35.91 mm | -69.61 mm | -55.89 mm | -33.75 mm | -28.35 mm |
| Runway (months of cash) | n/a | 1190.3 | -2.8 | -2.6 | -2.1 | -1.9 |
| 13F holders | Current |
|---|---|
| Total holders | 184 |
| Opened positions | 39 |
| Closed positions | 38 |
| Increased positions | 67 |
| Reduced positions | 48 |
| 13F shares | Current |
|---|---|
| Total value | 1.72 tn |
| Total shares | 73.69 mm |
| Total puts | 675.80 k |
| Total calls | 985.20 k |
| Total put/call ratio | 0.7 |
| Largest owners | Shares | Value |
|---|---|---|
| Wellington Management | 8.98 mm | $226.82 bn |
| BLK BlackRock | 5.48 mm | $138.50 bn |
| Kynam Capital Management | 5.06 mm | $127.97 bn |
| FMR | 4.86 mm | $122.75 bn |
| Vanguard | 3.88 mm | $98.10 bn |
| Eventide Asset Managment | 3.75 mm | $94.84 bn |
| T. Rowe Price | 3.56 mm | $89.89 mm |
| STT State Street | 3.23 mm | $81.75 bn |
| BLVGF Bellevue | 3.07 mm | $77.62 bn |
| Point72 Asset Management | 2.52 mm | $63.58 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 26 | Martin Samuel Bates | Common Stock | Option exercise | Acquire M | No | No | 10.38 | 4,817 | 50.00 k | 32,942 |
| 2 Jan 26 | Martin Samuel Bates | Incentive Stock Option Common Stock | Option exercise | Dispose M | No | No | 10.38 | 4,817 | 50.00 k | 58,815 |
| 15 Dec 25 | Pepin Ronald | Common Stock | Option exercise | Acquire M | No | No | 2.78 | 11,000 | 30.58 k | 20,097 |
| 15 Dec 25 | Pepin Ronald | Common Stock | Option exercise | Acquire M | No | No | 9.0165 | 8,333 | 75.13 k | 9,097 |
| 15 Dec 25 | Pepin Ronald | Incentive Stock Option Common Stock | Option exercise | Dispose M | No | No | 2.78 | 11,000 | 30.58 k | 0 |
| 15 Dec 25 | Pepin Ronald | Incentive Stock Option Common Stock | Option exercise | Dispose M | No | No | 9.0165 | 8,333 | 75.13 k | 5,000 |
| 4 Dec 25 | Freddy A. Jimenez | Common Stock | Sell | Dispose S | No | No | 29.095 | 4,166 | 121.21 k | 30,796 |
| 13 Nov 25 | Wright Richard M. | Common Stock | Sell | Dispose S | No | No | 24.0005 | 49,298 | 1.18 mm | 20,833 |
| 13 Nov 25 | Wright Richard M. | Common Stock | Option exercise | Acquire M | No | No | 22.48 | 15,750 | 354.06 k | 70,131 |
| 13 Nov 25 | Wright Richard M. | Common Stock | Option exercise | Acquire M | No | No | 10.38 | 26,672 | 276.86 k | 54,381 |